Abstracts

1314 – Hair Salons as a Promising Space to Offer HIV Prevention Services for Young Women in Lesotho

Background Adolescent girls and young women in southern Africa are disproportionately affected by HIV and sexual reproductive health (SRH) challenges. There is a need for more accessible and de-medicalized community spaces to offer person-centred HIV/SRH services for this key population. We aimed to assess the acceptability and feasibility of offering HIV/SRH services at hair salons…

1362 – Disposition of Referrals for Long-Acting Antiretrovirals at the Ward 86 HIV Clinic in San Francisco

Background Ward 86, a safety-net HIV clinic in San Francisco for ~2,600 publicly insured patients, has been using long-acting antiretroviral therapy (LA ART) for people living with HIV (PWH) with adherence challenges to oral ART. Since the approval of cabotegravir/rilpivirine (CAB/RPV) in 2021 and lenacapavir (LEN) in 2022, PWH have been referred to the Special…

1303 – Effects of a Cash Transfer Intervention on Internalized HIV Stigma Among ART Initiates in Tanzania

Background Retention in care remains a significant challenge for People Living with HIV (PLHIV) in Tanzania, possibly worsened by internalized HIV stigma and other factors leading to lower clinic attendance and treatment failure despite existing interventions. Financial incentives have emerged as a promising intervention for addressing social determinants of health potentially mitigating internalized HIV stigma…

1360 – Clinical Consequences of Delaying Implementation of LA-ART for PWH With Persistent Viremia in the US

Background Long-acting (LA-) injectable cabotegravir-rilpivirine (CAB/RPV) can achieve viral suppression (VS) in PWH with poor adherence to daily ART and persistent viremia. While current DHHS guidelines recommend this indication for CAB/RPV on a case-by-case basis, the FDA is requiring a randomized trial for approval. Our objective was to project the clinical impact of delaying CAB/RPV…

1294 – Cost-Effectiveness of PrEP and Medications for Opioid Use Disorder in People Who Inject Drugs

Background People who inject drugs (PWID) in the US have high HIV incidence and fatal overdose rates, yet uptake is low for pre-exposure prophylaxis (PrEP; 1%) and medications for opioid use disorder (MOUD; 18%). Long-acting PrEP and MOUD formulations may improve uptake and adherence. Methods Using the validated MYRIAD multimorbidity microsimulation model (accounting for impact…

1363 – Impact of 6-Monthly ART Dispensing on Retention in Malawi: A Target Trial Emulation Study

Background Malawi implemented 6-multi-month dispensing (6MMD) of antiretroviral therapy (ART) for clinically stable clients on HIV treatment during 2019 and scaled-up implementation in 2020. We compared retention for clients who received 6MMD to those who did not receive 6MMD and assessed predictors of retention. Methods We applied a target trial emulation (TTE) approach using routine…

1302 – Depression and Suicide Risk Among Sexual and Gender Minorities: Insights From the ImPrEP CAB Brasil

Background Mental health plays an important role in the effectiveness of HIV prevention strategies, as poor mental health can lead to decreased adherence and increased vulnerability to HIV infection. Long-acting PrEP modalities can help overcome barriers related to PrEP persistence and adherence, and should be considered for those with mental health challenges. We explored the…